Earnings History Data for Arcus Biosciences, Inc. (RCUS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Arcus Biosciences, Inc.

Arcus Biosciences is a biopharmaceutical company. It focused on creating innovative cancer immunotherapies. The company's product portfolio includes AB928, AB122, AB154 and AB680. AB928 which is in its final phase is a potent and selective dual antagonist of the adenosine receptors. AB122 which is in its Phase1 is a monoclonal antibody which potently and selectively blocks a protein called PD-1. AB154 is a monoclonal antibody which potently and selectively blocks a novel immune checkpoint called TIGIT. AB680, which is in its Phase1 is a potent and selective inhibitor of CD73, the enzyme responsible for the extracellular production of adenosine within the tumor micro-environment. Arcus Biosciences is based in Hayward, CA.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
06-11-2024 AH RCUS Arcus Biosciences, Inc. 1,420 -1.00 -1.07 -0.94 Arcus Biosciences GAAP EPS of -$1.00 beats by $0.04, revenue of $48M beats by $9.05M
[11/6/2024 6:32 PM]		 16.44 0.71 
(4.51%)		 16.15 0.42 
(2.67%)		 12.95 - 20.31 2,309,388 830,000 93,308
08-08-2024 PM RCUS Arcus Biosciences, Inc. 1,320 -1.02 -1.02 -1.04 Arcus Biosciences GAAP EPS of -$1.02 beats by $0.11, revenue of $39M beats by $12.51M
[8/9/2024 1:28 AM]		 15.53 1.84 
(13.44%)		 13.69 0.0 
(0.00%)		 12.95 - 25.47 657,274 540,000 11,395
08-05-2024 AH RCUS Arcus Biosciences, Inc. 1,450 -0.05 -0.97 -1.09 Arcus Biosciences GAAP EPS of -$0.05 beats by $0.92, revenue of $145M beats by $116.23M
[5/8/2024 4:36 PM]		 16.29 1.03 
(6.75%)		 16.00 0.74 
(4.85%)		 12.95 - 25.47 643,621 490,000 329
21-02-2024 AH RCUS Arcus Biosciences, Inc. 1,260 -1.08 -1.09 -0.93 Arcus Biosciences GAAP EPS of -$1.08 misses by $0.06, revenue of $31M beats by $2.7M
[2/21/2024 5:57 PM]		 19.63 3.22 
(19.65%)		 17.00 0.59 
(3.60%)		 12.95 - 25.47 3,004,196 930,000 27,731
07-11-2023 AH RCUS Arcus Biosciences, Inc. 1,220 -0.94 -1.12 -0.90 Arcus Biosciences GAAP EPS of -$0.94 beats by $0.19, revenue of $32M beats by $4.44M
[11/7/2023 4:24 PM]		 15.99 -0.46 
(-2.77%)		 16.55 0.10 
(0.61%)		 14.33 - 36.13 661,924 950,000 32,212
07-08-2023 PM RCUS Arcus Biosciences, Inc. 1,390 -1.04 1.00 -0.93 Arcus Biosciences GAAP EPS of -$1.04, revenue of $29M
[8/7/2023 8:39 AM]		 18.25 -0.77 
(-4.07%)		 18.76 -0.26 
(-1.37%)		 15.70 - 36.13 463,255 670,000 301
09-05-2023 AH 4:00 PM ET
(May 9)		 RCUS Arcus Biosciences, Inc. 1,430 -1.09 -1.06 -0.96 Arcus Biosciences GAAP EPS of -$1.09 beats by $0.10, revenue of $25M beats by $2.53M
[5/9/2023 5:31 PM]		 18.83 -0.57 
(-2.94%)		 19.40 0.0 
(0.00%)		 15.70 - 36.13 726,067 790,000 12,116
28-02-2023 AH RCUS Arcus Biosciences, Inc. 1,380 -0.93 -0.99 3.71 Arcus Biosciences GAAP EPS of -$0.93 beats by $0.17, revenue of $34M beats by $10.28M
[2/28/2023 5:33 PM]		 17.43 -0.78 
(-4.26%)		 18.09 -0.12 
(-0.66%)		 16.74 - 39.75 1,312,549 780,000 24,704
02-11-2022 AH RCUS Arcus Biosciences, Inc. 1,840 -0.90 -1.05 -1.11 Arcus Biosciences GAAP EPS of -$0.90 beats by $0.17
[11/2/2022 5:26 PM]		 24.48 0.0 
(0.00%)		 23.95 -0.53 
(-2.17%)		 16.74 - 49.10 613,289 960,000 105
03-08-2022 AH 4:00 PM ET
(Aug 3)		 RCUS Arcus Biosciences, Inc. 1,920 -0.93 -0.93 -1.09 Arcus Biosciences GAAP EPS of -$0.93 beats by $0.01, revenue of $26.8M beats by $5.23M
[8/3/2022 5:31 PM]		 26.77 0.43 
(1.61%)		 3.92 -0.40 
(-9.26%)		 16.74 - 49.10 674,052 520,000 51,552
09-05-2022 AH 4:05 PM ET
(May 9)		 RCUS Arcus Biosciences, Inc. 1,640 -0.96 0.83 -1.08 Arcus Biosciences GAAP EPS of -$0.96 misses by $0.17, revenue of $18.01M misses by $9.99M
[5/9/2022 5:20 PM]		 24.01 2.51 
(11.67%)		 22.08 0.58 
(2.70%)		 20.49 - 49.10 1,343,071 1,106,638 201
08-11-2021 AH 4:10 PM ET
(Nov 8)		 RCUS Arcus Biosciences, Inc. 2,530 -1.11 -1.13 0.03 39.08 4.34 
(12.49%)		 36.50 1.76 
(5.07%)		 19.86 - 42.36 918,903 370,000 196,267
05-08-2021 AH 4:10 PM ET
(Aug 5)		 RCUS Arcus Biosciences, Inc. 2,130 -1.09 -0.77 -0.93 Arcus Biosciences EPS misses by $0.20, misses on revenue
[8/5/2021 4:23 PM]		 27.25 -3.23 
(-10.60%)		 30.48 0.0 
(0.00%)		 16.69 - 42.36 817,105 350,000 3,572
05-05-2021 AH 4:10 PM ET
(May 5)		 RCUS Arcus Biosciences, Inc. 2,370 -1.08 -0.70 -0.63 Arcus Biosciences EPS misses by $0.24, misses on revenue
[5/5/2021 5:10 PM]		 30.13 -0.81 
(-2.62%)		 30.13 0.0 
(0.00%)		 16.69 - 42.36 1,144,021 430,000 11,563
24-02-2021 AH 4:10 PM ET
(Feb 24)		 RCUS Arcus Biosciences, Inc. 2,101 -0.82 -0.62 0.00 Arcus Biosciences EPS misses by $0.11, beats on revenue
[2/24/2021 5:07 PM]		 34.40 -0.93 
(-2.63%)		 34.90 -0.43 
(-1.22%)		 9.85 - 42.36 374,113 598,611 1,195